Cross Country Healthcare, Inc. (CCRN)
USD 14.21
(-0.42%)
USD 14.21
(-0.42%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.26 Million USD | -96.66% |
| 2022 | 157.74 Million USD | -19.3% |
| 2021 | 195.48 Million USD | 167.23% |
| 2020 | 73.15 Million USD | -22.94% |
| 2019 | 94.92 Million USD | 14.12% |
| 2018 | 83.17 Million USD | -16.09% |
| 2017 | 99.13 Million USD | 13.92% |
| 2016 | 87.02 Million USD | -3.17% |
| 2015 | 89.87 Million USD | 21.33% |
| 2014 | 74.07 Million USD | 763.74% |
| 2013 | 8.57 Million USD | -74.67% |
| 2012 | 33.85 Million USD | -19.47% |
| 2011 | 42.04 Million USD | -21.43% |
| 2010 | 53.51 Million USD | -14.4% |
| 2009 | 62.51 Million USD | -53.03% |
| 2008 | 133.08 Million USD | 237.33% |
| 2007 | 39.45 Million USD | 83.25% |
| 2006 | 21.52 Million USD | -15.34% |
| 2005 | 25.42 Million USD | -39.85% |
| 2004 | 42.27 Million USD | -54.9% |
| 2003 | 93.73 Million USD | 118.94% |
| 2002 | 42.81 Million USD | -12.38% |
| 2001 | 48.86 Million USD | -68.93% |
| 2000 | 157.27 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 4.49 Million USD | -14.71% |
| 2024 Q2 | 4.73 Million USD | 5.45% |
| 2023 FY | 5.26 Million USD | -96.66% |
| 2023 Q3 | 5.82 Million USD | -84.45% |
| 2023 Q1 | 145.87 Million USD | -7.53% |
| 2023 Q4 | 5.26 Million USD | -9.53% |
| 2023 Q2 | 37.44 Million USD | -74.33% |
| 2022 Q1 | 233.95 Million USD | 19.68% |
| 2022 Q2 | 216.53 Million USD | -7.44% |
| 2022 FY | 157.74 Million USD | -19.3% |
| 2022 Q4 | 157.74 Million USD | 12.89% |
| 2022 Q3 | 139.73 Million USD | -35.47% |
| 2021 Q4 | 195.48 Million USD | 64.64% |
| 2021 Q3 | 118.73 Million USD | -10.09% |
| 2021 Q2 | 132.05 Million USD | 15.02% |
| 2021 FY | 195.48 Million USD | 167.23% |
| 2021 Q1 | 114.8 Million USD | 56.94% |
| 2020 Q3 | 76.53 Million USD | 8.19% |
| 2020 Q4 | 73.15 Million USD | -4.42% |
| 2020 FY | 73.15 Million USD | -22.94% |
| 2020 Q1 | 90.6 Million USD | -4.55% |
| 2020 Q2 | 70.74 Million USD | -21.92% |
| 2019 Q1 | 102.97 Million USD | 23.8% |
| 2019 Q2 | 97.19 Million USD | -5.62% |
| 2019 Q4 | 94.92 Million USD | -0.71% |
| 2019 Q3 | 95.6 Million USD | -1.63% |
| 2019 FY | 94.92 Million USD | 14.12% |
| 2018 FY | 83.17 Million USD | -16.09% |
| 2018 Q4 | 83.17 Million USD | -8.18% |
| 2018 Q3 | 90.58 Million USD | -6.37% |
| 2018 Q2 | 96.74 Million USD | -1.22% |
| 2018 Q1 | 97.93 Million USD | -1.21% |
| 2017 FY | 99.13 Million USD | 13.92% |
| 2017 Q4 | 99.13 Million USD | 3.99% |
| 2017 Q3 | 95.33 Million USD | 169.72% |
| 2017 Q2 | 35.34 Million USD | -2.28% |
| 2017 Q1 | 36.16 Million USD | -58.44% |
| 2016 Q3 | 72.5 Million USD | -9.1% |
| 2016 Q2 | 79.77 Million USD | 11.86% |
| 2016 FY | 87.02 Million USD | -3.17% |
| 2016 Q4 | 87.02 Million USD | 20.02% |
| 2016 Q1 | 71.31 Million USD | -20.65% |
| 2015 Q4 | 89.87 Million USD | 24.81% |
| 2015 Q2 | 71.75 Million USD | -4.67% |
| 2015 FY | 89.87 Million USD | 21.33% |
| 2015 Q3 | 72 Million USD | 0.34% |
| 2015 Q1 | 75.27 Million USD | 1.62% |
| 2014 Q2 | 64.79 Million USD | 231.54% |
| 2014 Q1 | 19.54 Million USD | 127.89% |
| 2014 Q3 | 65.35 Million USD | 0.87% |
| 2014 Q4 | 74.07 Million USD | 13.34% |
| 2014 FY | 74.07 Million USD | 763.74% |
| 2013 Q3 | 255 Thousand USD | -28.57% |
| 2013 Q2 | 357 Thousand USD | -25.78% |
| 2013 Q1 | 481 Thousand USD | -98.58% |
| 2013 FY | 8.57 Million USD | -74.67% |
| 2013 Q4 | 8.57 Million USD | 3263.14% |
| 2012 Q1 | 39.73 Million USD | -5.49% |
| 2012 FY | 33.85 Million USD | -19.47% |
| 2012 Q2 | 36.22 Million USD | -8.83% |
| 2012 Q4 | 33.85 Million USD | -1.88% |
| 2012 Q3 | 34.5 Million USD | -4.75% |
| 2011 Q4 | 42.04 Million USD | -8.5% |
| 2011 Q1 | 51.89 Million USD | -3.02% |
| 2011 Q3 | 45.95 Million USD | -8.03% |
| 2011 Q2 | 49.96 Million USD | -3.72% |
| 2011 FY | 42.04 Million USD | -21.43% |
| 2010 Q1 | 57.24 Million USD | -8.43% |
| 2010 FY | 53.51 Million USD | -14.4% |
| 2010 Q3 | 55.1 Million USD | -2.21% |
| 2010 Q4 | 53.51 Million USD | -2.89% |
| 2010 Q2 | 56.35 Million USD | -1.56% |
| 2009 Q3 | 69.48 Million USD | -25.32% |
| 2009 FY | 62.51 Million USD | -53.03% |
| 2009 Q4 | 62.51 Million USD | -10.03% |
| 2009 Q2 | 93.03 Million USD | -20.78% |
| 2009 Q1 | 117.44 Million USD | -11.75% |
| 2008 Q4 | 133.08 Million USD | -7.84% |
| 2008 Q2 | 34.34 Million USD | -18.51% |
| 2008 Q1 | 42.14 Million USD | 6.82% |
| 2008 FY | 133.08 Million USD | 237.33% |
| 2008 Q3 | 144.4 Million USD | 320.51% |
| 2007 FY | 39.45 Million USD | 83.25% |
| 2007 Q2 | 29 Million USD | 10.04% |
| 2007 Q4 | 39.45 Million USD | -10.57% |
| 2007 Q3 | 44.11 Million USD | 52.09% |
| 2007 Q1 | 26.35 Million USD | 22.44% |
| 2006 FY | 21.52 Million USD | -15.34% |
| 2006 Q4 | 21.52 Million USD | 4.1% |
| 2006 Q3 | 20.68 Million USD | 98.25% |
| 2006 Q2 | 10.43 Million USD | -44.34% |
| 2006 Q1 | 18.74 Million USD | -26.3% |
| 2005 Q4 | 25.42 Million USD | -18.69% |
| 2005 Q3 | 31.27 Million USD | -18.49% |
| 2005 Q1 | 41.57 Million USD | -1.66% |
| 2005 Q2 | 38.37 Million USD | -7.7% |
| 2005 FY | 25.42 Million USD | -39.85% |
| 2004 FY | 42.27 Million USD | -54.9% |
| 2004 Q3 | 60.42 Million USD | -13.13% |
| 2004 Q2 | 69.55 Million USD | -20.5% |
| 2004 Q1 | 87.49 Million USD | -6.66% |
| 2004 Q4 | 42.27 Million USD | -30.03% |
| 2003 Q1 | 27.49 Million USD | -35.78% |
| 2003 Q3 | 118.92 Million USD | -5.01% |
| 2003 FY | 93.73 Million USD | 118.94% |
| 2003 Q2 | 125.19 Million USD | 355.32% |
| 2003 Q4 | 93.73 Million USD | -21.18% |
| 2002 FY | 42.81 Million USD | -12.38% |
| 2002 Q4 | 42.81 Million USD | -5.48% |
| 2002 Q3 | 45.29 Million USD | -0.45% |
| 2002 Q1 | 46.07 Million USD | -5.72% |
| 2002 Q2 | 45.5 Million USD | -1.24% |
| 2001 Q4 | 48.86 Million USD | -73.45% |
| 2001 FY | 48.86 Million USD | -68.93% |
| 2001 Q3 | 184.06 Million USD | 0.0% |
| 2000 FY | 157.27 Million USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 99.651% |
| Addus HomeCare Corporation | 175.18 Million USD | 96.993% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | 94.715% |
| Amedisys, Inc. | 487.21 Million USD | 98.919% |
| American Oncology Network, Inc. | 128.32 Million USD | 95.896% |
| Astrana Health, Inc. | 321.01 Million USD | 98.359% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 99.649% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | 95.415% |
| Cryo-Cell International, Inc. | 10.89 Million USD | 51.661% |
| COMPASS Pathways plc | 33.04 Million USD | 84.064% |
| DocGo Inc. | 46.49 Million USD | 88.672% |
| The Ensign Group, Inc. | 1.87 Billion USD | 99.719% |
| Healthcare Services Group, Inc. | 43.63 Million USD | 87.929% |
| InnovAge Holding Corp. | 113.03 Million USD | 95.34% |
| Assure Holdings Corp. | 14.8 Million USD | 64.424% |
| The Joint Corp. | 16.73 Million USD | 68.527% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 98.969% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -701.512% |
| ModivCare Inc. | 1.14 Billion USD | 99.538% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -1483.808% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -17.787% |
| Option Care Health, Inc. | 1.16 Billion USD | 99.548% |
| P3 Health Partners Inc. | 124.64 Million USD | 95.774% |
| P3 Health Partners Inc. | 124.64 Million USD | 95.774% |
| The Pennant Group, Inc. | 329.63 Million USD | 98.402% |
| Surgery Partners, Inc. | 3.06 Billion USD | 99.828% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -2022.909% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | 95.604% |
| The Oncology Institute, Inc. | 119.81 Million USD | 95.604% |